S-2005 DJK SOCIAL SECURITY DISABILITY ADVOCACY COMPANY

 

Social Security Disability Advocacy Company

Acquisition Opportunity - Southeast

This company is in the unique and specialized Social Security Disability Advocacy business.  With four years of operations, the company’s case acquisition model with proprietary algorithm has been sharpened and refined resulting in the company experiencing case success outcomes that exceed the industry average by more than 20% leading to superior customer satisfaction and financial results. 

Company is now seeking additional funding in order to expand its case acquisition capacity.  The company has built a national advocate network enabling it to accept cases on an unlimited and national basis. Company business model is highly predictable and scalable.

Experienced management team with over ten (10) years of highly successful, specialized social security disability program advocacy work. Losses have been uncured in the early years of the business as the number of cases carried is built to critical mass needed to achieve economies of scale.  Company is currently passing this critical inflection point and is heading to predictable operating efficiencies and profitability

Funding will be utilized to; acquire and carry cases, an average of eighteen (18) months, through disposition, and to build corresponding administrative support structure commensurate with case management.  Existing management team will be remaining with company and is interested in maintaining a negotiable degree of control.

 

 

Financial Summary
	2021 Est by Seller	2020 Est by Seller	2019
Revenue	$3 Mil	$2 Mil	$1 Mil
Adjusted EBITDA	$500,000	($300,000)	($1.3 Mil)

 

 

Other Highlights
Financials	Management Team in Place	Years in Business	SIC
Yes	Yes	4	8322

 

 

 

 

 

 

 

---

Gottesman Company

Refer to:  S-2005  DJK

  US Office:  718-618-5346     UK Office: +44 (0)790678650

E-mail: dmj@gottesman-company.com

S-3053-1 MJK Radiation Oncology Center

 

Radiation Oncology Center

3 City Locations

 

The Oncology Center provides various medical radiation oncology treatments at locations in three city locations in the northeast US. The core medical team members were graduated from U.S. medical schools, such as Yale and Pennsylvania University. Most physicians have extensive working experience in renowned oncology hospitals in the U.S., such as Memorial Sloan-Kettering Cancer Center.

 

The Oncology Center provides exceptional medical care to patients with state-of-the-art radiation therapies including 3D-CRT, IGRT, IMRT and VMAT, etc. Their advanced treatment equipment includes Varian’s Edge and Halcyon, Accuray’s Cyberknife, Elekta Synergy and the HDR Brachytherapy system. These are all supported by CT/ MR/ PET-CT.

 

There is one shareholder, who also owns the real estate where the treatment sites are located. The real estate can be included in the transaction should the buyer wish. The owner is willing to hold minority equity in the business post close.

 

 

 

Financial Summary $000s
	**2019	*2018	2017
Gross Revenue	10,456	9,292	10,387
EBITDA	3,925	2,644	2,593

*Decline of revenue in 2018 due to improvement of radiotherapy methodology, resulting in increased radiotherapy dosage, leading to decrease of fractions.

**Revenue of $8,849,000 in 2019 has been confirmed by insurance companies. Additional revenue of approximately $1,607,000 is still being confirmed by insurance companies. 2019 annual income is estimated to be $10,456,000.

 

Other Highlights
Financials	Management Team in Place	Years in Business	NAICS
Reviewed	Yes	12	621111

 

 

 

 

 

 

 

---

Gottesman Company

 Refer to:  S-3053-1 MJK

  US Office:  718-618-5346     UK Office: +44 (0)790678650

E-mail: dmj@gottesman-company.com